A detailed history of Patrick M Sweeney & Associates, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Patrick M Sweeney & Associates, Inc holds 74,439 shares of ABT stock, worth $8.58 Million. This represents 6.24% of its overall portfolio holdings.

Number of Shares
74,439
Previous 74,272 0.22%
Holding current value
$8.58 Million
Previous $7.72 Billion 9.97%
% of portfolio
6.24%
Previous 6.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$100.07 - $118.13 $16,711 - $19,727
167 Added 0.22%
74,439 $8.49 Billion
Q2 2024

Jul 17, 2024

BUY
$100.73 - $112.44 $27,297 - $30,471
271 Added 0.37%
74,272 $7.72 Billion
Q1 2024

Apr 25, 2024

BUY
$109.52 - $120.96 $10,952 - $12,096
100 Added 0.14%
74,001 $8.41 Billion
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $6.67 Million - $8.16 Million
73,901 New
73,901 $8.13 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $202B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Patrick M Sweeney & Associates, Inc Portfolio

Follow Patrick M Sweeney & Associates, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patrick M Sweeney & Associates, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patrick M Sweeney & Associates, Inc with notifications on news.